Dr Miloš Filipović is the research group leader at the Leibniz Institute for Analytical Sciences (ISAS) in Dortmund. His research interests are quite broad: from understanding the basic chemical steps behind intracellular metabolic pathways to regulation and treatment of different disease states. The focus of his research is redox biology, particularly elucidating the mechanisms by which hydrogen sulfide controls our body functions through protein persulfidation (S-sulfhydration) and could be used for therapeutic purposes, such as lifespan extension (anti-aging). After finished PhD at the Faculty of Chemistry, University of Belgrade, he moved to Friedrich-Alexander University Erlangen-Nuremberg, first as a postdoc and then as a habilitated in the field of biological chemistry. For the habilitation work/research, dr Filipović received the Emmy Noether Prize. In 2015 he got a CR1 position at CNRS, ATIP Avenir grant, and Idex Junior Chair grant from the University of Bordeaux, where he started his group at IBGC UMR5095. In 2019 received an ERC consolidator grant. He has published 81 papers in international peer-reviewed journals in the research area, which were cited 5118 times excluding self-citations (h-index =38, Scopus).